Study on the pharmacodynamic material basis of network pharmacology of "Duhuo-sangjisheng" pair in the treatment of Rheumatoid arthritis

Authors

  • Chengcheng Zhao Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Yingqi Wang Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Shiyi Xu Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Yingchun Zhou Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Miao Tian Heilongjiang University of Chinese Medicine, Harbin 150040, China
  • Yuzhou Shang Heilongjiang University of Chinese Medicine, Harbin 150040, China

Abstract

Rheumatoid arthritis (RA) is a chronic systemic disease with unknown etiology, mainly inflammatory synovitis. Based on the theory background of Duhuojisheng Decoction in “BeiJiQianJin Yaofang”,this paper takes Duhuo Jisheng decoction as the theoretical background, and develops the network pharmacology pharmacodynamic material basis of its compatibility in the treatment of rheumatoid arthritis. Firstly, TCMSP database was used to sort out the effective components and target genes. Next, gene cards database was used to collect disease-related genes, and then a four-dimensional relationship network of "drug-active ingredient-target gene-disease" was established. Finally, PubChem database was used to sort out the predicted components and summarize the pharmacodynamic basis.To some extent, it shows the significance of Duhuo Jisheng Decoction in the treatment of rheumatoid arthritis.

Downloads

Published

2024-08-22

Issue

Section

Articles